Cardio Diagnostics Holdings Stock Earnings Per Share
| CDIOW Stock | USD 0.06 0.0009 1.55% |
Cardio Diagnostics Holdings fundamentals help investors to digest information that contributes to Cardio Diagnostics' financial success or failures. It also enables traders to predict the movement of Cardio Stock. The fundamental analysis module provides a way to measure Cardio Diagnostics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cardio Diagnostics stock.
Cardio | Earnings Per Share |
Cardio Diagnostics Holdings Company Earnings Per Share Analysis
Cardio Diagnostics' Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Cardio Earnings Per Share Driver Correlations
Understanding the fundamental principles of building solid financial models for Cardio Diagnostics is extremely important. It helps to project a fair market value of Cardio Stock properly, considering its historical fundamentals such as Earnings Per Share. Since Cardio Diagnostics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Cardio Diagnostics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Cardio Diagnostics' interrelated accounts and indicators.
Click cells to compare fundamentals
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
| Competition |
Cardio Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
According to the company disclosure, Cardio Diagnostics Holdings has an Earnings Per Share of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The earnings per share for all United States stocks is 100.0% higher than that of the company.
Cardio Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cardio Diagnostics' direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cardio Diagnostics could also be used in its relative valuation, which is a method of valuing Cardio Diagnostics by comparing valuation metrics of similar companies.Cardio Diagnostics is currently under evaluation in earnings per share category among its peers.
Cardio Fundamentals
| Return On Equity | -2.93 | ||||
| Return On Asset | -0.98 | ||||
| Operating Margin | (162.96) % | ||||
| Number Of Shares Shorted | 15.42 K | ||||
| Revenue | 17.07 K | ||||
| EBITDA | (1.53 M) | ||||
| Net Income | (8.38 M) | ||||
| Total Debt | 1.26 M | ||||
| Book Value Per Share | 0.14 X | ||||
| Cash Flow From Operations | (5.67 M) | ||||
| Beta | 4.68 | ||||
| Total Asset | 4.46 M | ||||
| Retained Earnings | (14.37 M) | ||||
| Working Capital | 1.92 M | ||||
| Net Asset | 4.46 M |
About Cardio Diagnostics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cardio Diagnostics Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cardio Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cardio Diagnostics Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Cardio Stock Analysis
When running Cardio Diagnostics' price analysis, check to measure Cardio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardio Diagnostics is operating at the current time. Most of Cardio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Cardio Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardio Diagnostics' price. Additionally, you may evaluate how the addition of Cardio Diagnostics to your portfolios can decrease your overall portfolio volatility.